Sage Therapeutics Inc SAGE Valuation Ratios and Share Stats

S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Sage Therapeutics Inc (SAGE)
Sage Therapeutics Inc (SAGE) Financials

Sage Therapeutics Inc (SAGE)

7.18

0.04

(0.56%)

Closed February 18 3:00PM

Delayed by 15 minutes

7.18

0.00

( 0.00% )

Pre Market: 3:00AM

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End December 30 2024	2017	2018	2019	2020	2021	2022	2023	2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-57.813	-50.3	-66.793	37.373	-22.983	-33.49	-48.375	-56.057
Return on Equity (%)	-64.01	-55.719	-75.263	40.177	-24.091	-35.738	-52.773	-63.365
Return on Invested Capital (%)	-64.838	-58.902	-78.72	39.672	-24.317	-36.833	-56.861	-68.97
Operating Margin (%)	N/A	-413.06	-9904.455	54.395	-7258.909	-6931.876	-626.325	-971.476
Net Profit Margin (%)	N/A	-413.06	-9904.455	54.395	-7258.909	-6931.876	-626.325	-971.476
Book Value Per Share	11.32	18.405	18.21	35.541	29.337	21.049	13.333	7.603
Earnings Per Share	-6.431	-7.953	-13.113	10.394	-7.769	-8.953	-9.03	-6.55
Cash Per Share	7.291	4.072	2.442	28.488	4.992	2.734	1.184	1.324
Working Capital Per Share	11.264	18.313	17.791	35.247	29.107	20.799	13.117	7.515
Operating Profit Per Share	N/A	1.925	0.125	19.099	0.098	0.115	1.406	0.52
EBIT Per Share	-6.431	-7.953	-13.113	10.394	-7.769	-8.953	-9.03	-6.55
EBITDA Per Share	-6.431	-7.953	-13.113	10.394	-7.769	-8.953	-9.03	-6.55
Free Cash Flow Per Share	-6.411	-7.916	-13.046	10.355	-7.834	-8.956	-9.044	-6.567

Liquidity Ratios

Year End December 30 2024	2017	2018	2019	2020	2021	2022	2023	2024
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	42M	46.89M	51.88M	58.31M	58.94M	59.51M	N/A	N/A

Key Stats and Ratios

Year End December 30 2024	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	-4457.438	N/A	N/A	N/A	-1372.855	N/A	N/A	N/A
Net Profit Margin (%)	-4457.438	N/A	N/A	N/A	-1372.855	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	441.43M
Price to Earnings Ratio	-1.1
Price to Sales Ratio	10.7
Price to Cash Ratio	5.45
Price to Book Ratio	0.95
Dividend Yield	-

Share Statistics

Shares Outstanding	61.48M
Average Volume (1 week)	1.83M
Average Volume (1 Month)	1.76M
52 Week Change	-68.98%
52 Week High	23.22
52 Week Low	4.62

More Ratios Coming Soon!

Sage Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions